Maqola

1141 Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer

Keiichi KontaniKagawa University Faculty of Medicine, Department of Respiratory Breast and Ecdocrine Surgery, Kagawa, Japan,S. HashimotoInstitute of Molecular Biology and Genetics, Cell Signaling, Kyiv, UkraineChisa MurazawaInstitute of Molecular Biology and Genetics, Cell Signaling, Kyiv, UkraineM. OhtaniManabu DateAkira YamauchiKitano Hospital, Department of Breast Surgery, Osaka, Japan,H. YokomiseKagawa University Faculty of Medicine, Department of Respiratoy Breast and Endocrine Surgery, Kagawa, Japan

European Journal of Cancerjournal2012en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

HER2/EGFR in Cancer Research

Identifikatorlar

DOI: 10.1016/s0959-8049(12)71737-9

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba